Research programme: mRNA based herpes zoster vaccine - BioNTech/Pfizer
Alternative Names: mRNA HPV vaccine - BioNTech/Pfizer; Shingles vaccine programme - BioNTechLatest Information Update: 28 Jun 2022
At a glance
- Originator BioNTech; Pfizer
- Class RNA vaccines; Varicella vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Herpes zoster
Most Recent Events
- 31 May 2022 Preclinical trials in Herpes zoster (Prevention) in Germany (Parenteral) before May 2022
- 31 May 2022 Preclinical trials in Herpes zoster (Prevention) in USA (Parenteral) before May 2022
- 05 Jan 2022 BioNTech and Pfizer plans a clinical trial for Herpes zoster (Prevention) in the second half of 2022